跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUTYLIN SYRUP 1.5 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
BUTYLIN SYRUP 1.5 mg/5 ml
Approved
THERAPEUTIC
BUTYLIN SYRUP 1.5 mg/5 ml
HOVID BHD
🇸🇬 Health Sciences Authority
Approval Date
Mar 18, 1995
Approval ID
184a8d799dce383c
Company
HOVID BHD
Type
Therapeutic
Approval Details
Approval Id
184a8d799dce383c
Drug Name
BUTYLIN SYRUP 1.5 mg/5 ml
Product Name
BUTYLIN SYRUP 1.5 mg/5 ml
Approval Number
SIN08075P
Approval Date
1995-03-18
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Pharmacy Only
Dosage Form
SYRUP
Route Of Administration
ORAL
Atc Code
R03CC03
Atc Item Name
terbutaline
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
TERBUTALINE SULPHATE
1.5 mg/5 ml
TERBUTALINE SULPHATE
1.5 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 18, 1995
Approval ID
184a8d799dce383c
Type
Therapeutic
Back to HSA Approvals